How many insider declarations has Juan Carlos Alvarez filed?

Juan Carlos Alvarez has filed 2 public insider declarations with SEBI (PIT + SAST).

What is Juan Carlos Alvarez's role?

Juan Carlos Alvarez's reported role is not specified by the regulator across the filings.

Which companies does Juan Carlos Alvarez report trades for?

Juan Carlos Alvarez reports trades for Dr. Reddy's Laboratories Limited.

← Executives ★ Sign in to follow

JC

Juan Carlos Alvarez

·SEBI (PIT + SAST)

Dr. Reddy's Laboratories Limited

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Explore the full record of transactions filed by Juan Carlos Alvarez. Director active across 1 company, notably Dr. Reddy's Laboratories Limited. Cumulatively, 2 disclosures have been published. Activity tracked since 3 August 2023. The latest transaction was filed on 29 August 2024 (Purchase). Regulator: SEBI (PIT + SAST). The full history is openly available.

Companies and markets linked to Juan Carlos Alvarez

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Dr. Reddy's Laboratories Limited (IN)IN insider transactions · SEBI (PIT + SAST)

申报2 总计

●

Juan Carlos Alvarez

高管2024年8月29日Dr. Reddy's Laboratories Limited

₹100万5SEBI ↗

145 股@ ₹6,914.0033.1% 占其流量ADR/GDR/FCCBSEBI:6fa92ed9233363a2096a34f71bebddd2f15c6897

●

Juan Carlos Alvarez

高管2023年8月3日Dr. Reddy's Laboratories Limited

₹198万9SEBI ↗

350 股@ ₹5,656.751466.9% 占其流量ADR/GDR/FCCBSEBI:3bb007e1686a261909d43d5fff6d838e9e568c45

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

JC

Juan Carlos Alvarez

·SEBI (PIT + SAST)

Dr. Reddy's Laboratories Limited

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Explore the full record of transactions filed by Juan Carlos Alvarez. Director active across 1 company, notably Dr. Reddy's Laboratories Limited. Cumulatively, 2 disclosures have been published. Activity tracked since 3 August 2023. The latest transaction was filed on 29 August 2024 (Purchase). Regulator: SEBI (PIT + SAST). The full history is openly available.